Lymphoma Clinical Trials

Showing 901-920 of 2,926 trials

GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma

NCT05335018

Prospective, open-ended, single-arm, multicenter Phase II clinical trial. To evaluate the efficacy of Glofitamab, Poseltinib, and Lenalidomide combination therapy in patients with relapsed/refractory diffuse large B-cell lymphoma.

Relapsed/refractory Diffuse Large B Cell Lymphoma

Seoul National University Hospital76 participantsStarted May 2022

Seoul, South Korea

RECRUITINGPhase 1

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

NCT06732492

This is a single-arm, open-label, single-center, phase I study. The primary objective is to evaluate the safety of CD7 Chimeric Antigen Receptor-T(CAR-T) therapy for patients with CD7-positive relapsed or refractory natural killer/T cell lymphoma, and to evaluate the pharmacokinetics of CD7 CAR-T in patients。

NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology10 participantsStarted Oct 2024

Wuhan, Hubei, China

COMPLETEDPhase 1

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

NCT03922204

This is an open-label, non-randomized, Phase 1 study to determine the safety, tolerability, and preliminary efficacy of MCLA-145 in adult patients with advanced metastatic solid tumors or B-cell lymphomas. The study will be conducted in 2 parts.

Advanced CancerSolid Tumor, AdultB-cell Lymphoma, Adult

Merus B.V.72 participantsStarted May 2019

La Jolla, California, United States • Boston, Massachusetts, United States • New York, New York, United States +5 more locations

GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

Related Searches

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

A Study of People With CD30 Positive Lymphoma in China

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT

The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia

Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: a Nationwide Study

A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma

Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)

A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma

To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007